[EN] PYRAZOLOPYRIMIDINE DERIVATIVES AS PI3 KINASE INHIBITORS<br/>[FR] DÉRIVÉS PYRAZOLOPYRIMIDINES EN TANT QU'INHIBITEURS DE PI3 KINASE
申请人:GLAXOSMITHKLINE LLC
公开号:WO2013028263A1
公开(公告)日:2013-02-28
The present invention relates to compounds of formula (I) in which R1, R2, R3 and n have the meaning given in the specification and also relates to the use of these pyrazolopyrimidine derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3'OΗ kinase family (hereinafter PI3 kinases), wherein the compounds of formula (I) are described as selective inhibitors of PI3K[beta] activity.
本发明涉及式(I)中R1、R2、R3和n的化合物,其中R1、R2、R3和n的含义如规范中所述,并且还涉及使用这些吡唑吡嘧啶衍生物来调节磷脂酰肌醇3'羟基激酶家族(以下简称PI3激酶)的活性或功能,其中式(I)的化合物被描述为PI3K[beta]活性的选择性抑制剂。